CeriBell, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 159.09K shares, a 77.28% decline year-over-year.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 232.78K shares, a 507.92% increase year-over-year.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 363.77K shares, a 555.27% increase year-over-year.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 349.79K shares.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.45M shares, a 258.99% increase from fiscal 2024.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 404.46K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 159.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 1.11M shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 232.78K shares 10-Q · filed 2026-05-11 | 1.65M shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 363.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 1.45M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 349.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 1.14M shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 700.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | |
| 2025-03-31 | 38.29K shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 55.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 404.46K shares 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |